Literature DB >> 17488731

Trends in pancreatic cancer incidence in nine SEER Cancer Registries, 1973-2002.

J Zhang1, I Dhakal, H Yan, M Phillips, H Kesteloot.   

Abstract

BACKGROUND: The evolution of pancreatic cancer incidence in the last three decades in the United States remains unclear. This study was conducted to investigate this problem, using data from the nine registries of the Surveillance, Epidemiology, and End Results (SEER) Program. PATIENTS AND METHODS: The incidence data in 1973-2002 were age standardized to the 2000 USA standard population and analyzed by the joinpoint regression.
RESULTS: For the nine registries combined, pancreatic cancer incidence in men significantly decreased by 0.62% per year from 1973 to 2002. Incidence in women increased until 1984 and slowly declined thereafter. A rise in incidence, although not statistically significant, has been noted in young and middle-aged adults (<60 years) since 1994. Changes in incidence over time substantially differed among the nine SEER registries compared. Incidence decreased in most age-, sex-, and race-specific groups of the populations covered in the nine registries during the period examined. Conversely, a statistically significant increase in incidence was observed among women in Hawaii and Iowa and among old adults (> or =60 years) in Seattle and Utah.
CONCLUSIONS: Pancreatic cancer incidence significantly decreased from 1973 to 2002 in men and increased until 1984 and then declined slowly in women in the United States.

Entities:  

Mesh:

Year:  2007        PMID: 17488731     DOI: 10.1093/annonc/mdm123

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  15 in total

1.  Novel nano-drug combination therapeutic regimen demonstrates significant efficacy in the transgenic mouse model of pancreatic ductal adenocarcinoma.

Authors:  Arvind Thakkar; Preshita Desai; Sushma Chenreddy; Jalpa Modi; Astrid Thio; Wael Khamas; David Ann; Jeffrey Wang; Sunil Prabhu
Journal:  Am J Cancer Res       Date:  2018-10-01       Impact factor: 6.166

2.  National trends in pancreatic cancer outcomes and pattern of care among Medicare beneficiaries, 2000 through 2010.

Authors:  Yun Wang; Deborah Schrag; Gabriel A Brooks; Francesca Dominici
Journal:  Cancer       Date:  2013-12-30       Impact factor: 6.860

3.  Single-center experience of laparoscopic left pancreatic resection in 359 consecutive patients: changing the surgical paradigm of left pancreatic resection.

Authors:  Ki Byung Song; Song Cheol Kim; Jae Berm Park; Young Hoon Kim; Young Soo Jung; Myung-Hwan Kim; Sung-Koo Lee; Dong-Wan Seo; Sang Soo Lee; Do Hyun Park; Duck Jong Han
Journal:  Surg Endosc       Date:  2011-05-10       Impact factor: 4.584

4.  African-Americans and Indigenous Peoples Have Increased Burden of Diseases of the Exocrine Pancreas: A Systematic Review and Meta-Analysis.

Authors:  Aya Cervantes; Ellen K Waymouth; Maxim S Petrov
Journal:  Dig Dis Sci       Date:  2018-09-27       Impact factor: 3.199

5.  Immunohistochemical features of the gastrointestinal tract tumors.

Authors:  Hannah H Wong; Peiguo Chu
Journal:  J Gastrointest Oncol       Date:  2012-09

6.  Bone marrow-derived progenitor cells could modulate pancreatic cancer tumorigenesis via peritumoral microenvironment in a rat model.

Authors:  Jen-Jung Pan; Seh-Hoon Oh; Wayne C Lee; Bryon E Petersen
Journal:  Oncol Res       Date:  2009       Impact factor: 5.574

7.  Occurrence of pancreatic, biliary tract, and gallbladder cancers in Alaska Native people, 1973-2007.

Authors:  Steven R Alberts; Janet J Kelly; Ramkumar Ashokkumar; Anne P Lanier
Journal:  Int J Circumpolar Health       Date:  2012-03-20       Impact factor: 1.228

8.  Impact of TP53 codon 72 and MDM2 SNP 309 polymorphisms in pancreatic ductal adenocarcinoma.

Authors:  Yasuki Hori; Katsuyuki Miyabe; Michihiro Yoshida; Takahiro Nakazawa; Kazuki Hayashi; Itaru Naitoh; Shuya Shimizu; Hiromu Kondo; Yuji Nishi; Shuichiro Umemura; Akihisa Kato; Hirotaka Ohara; Hiroshi Inagaki; Takashi Joh
Journal:  PLoS One       Date:  2015-03-03       Impact factor: 3.240

9.  Early onset pancreatic cancer: a controlled trial.

Authors:  Bobby Tingstedt; Carl Weitkämper; Roland Andersson
Journal:  Ann Gastroenterol       Date:  2011

10.  CD44+CD24+ subset of PANC-1 cells exhibits radiation resistance via decreased levels of reactive oxygen species.

Authors:  Lei Wang; Pengping Li; Wei Hu; Youyou Xia; Chenxi Hu; Liang Liu; Xiaodong Jiang
Journal:  Oncol Lett       Date:  2017-06-02       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.